Anhui Wanbang Pharmaceutical Technology Co., Ltd. has completed an IPO in the amount of CNY 1.131333 billion.

Anhui Wanbang Pharmaceutical Technology Co Ltd is a China-based company primarily engaged in the provision of pharmaceutical research and clinical research services as a comprehensive contract research organization (CRO). The Company mainly provides professional pharmaceutical research and development outsourcing services to pharmaceutical companies and other pharmaceutical research and development institutions. The Company's services mainly include pharmaceutical research services such as generic drug development and consistency evaluation services, as well as clinical research services such as clinical trial operations, clinical trial site management, biological sample analysis, data management and statistical analysis. The Company mainly operates its businesses in the domestic market.